- Home
- RVPH vs ANTX Comparison
RVPH vs ANTX Comparison
Compare RVPH & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- ANTX
- Stock Information
- Founded
- RVPH 2006
- ANTX 2017
- Country
- RVPH United States
- ANTX United States
- Employees
- RVPH N/A
- ANTX N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- RVPH Health Care
- ANTX Health Care
- Exchange
- RVPH Nasdaq
- ANTX Nasdaq
- Market Cap
- RVPH 32.8M
- ANTX 33.2M
- IPO Year
- RVPH N/A
- ANTX 2022
- Fundamental
- Price
- RVPH $0.38
- ANTX $1.08
- Analyst Decision
- RVPH Strong Buy
- ANTX Buy
- Analyst Count
- RVPH 5
- ANTX 2
- Target Price
- RVPH $9.00
- ANTX $2.00
- AVG Volume (30 Days)
- RVPH 3.8M
- ANTX 258.4K
- Earning Date
- RVPH 08-13-2025
- ANTX 08-12-2025
- Dividend Yield
- RVPH N/A
- ANTX N/A
- EPS Growth
- RVPH N/A
- ANTX N/A
- EPS
- RVPH N/A
- ANTX N/A
- Revenue
- RVPH N/A
- ANTX N/A
- Revenue This Year
- RVPH N/A
- ANTX N/A
- Revenue Next Year
- RVPH N/A
- ANTX N/A
- P/E Ratio
- RVPH N/A
- ANTX N/A
- Revenue Growth
- RVPH N/A
- ANTX N/A
- 52 Week Low
- RVPH $0.30
- ANTX $0.87
- 52 Week High
- RVPH $4.28
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- RVPH 34.83
- ANTX 48.42
- Support Level
- RVPH $0.38
- ANTX $1.05
- Resistance Level
- RVPH $0.45
- ANTX $1.10
- Average True Range (ATR)
- RVPH 0.05
- ANTX 0.04
- MACD
- RVPH 0.01
- ANTX 0.00
- Stochastic Oscillator
- RVPH 52.37
- ANTX 50.00
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.